MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

Home・Aandelen Lijst・Pulse Biosciences Inc

Pulse Biosciences Inc

Gesloten

SectorGezondheidszorg

13.23 -3.36

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

13.08

Max

13.69

Belangrijke statistieken
By Trading Economics
Inkomsten	-217K -19M
Verkoop	86K 86K
EPS	-0.29
Winstmarge	-22,540.698
Werknemers	75
EBITDA	-228K -19M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+60.23% upside

Dividenden
By Dow Jones
Volgende Winsten	26 mrt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-179M 958M
Vorige openingsprijs	16.59
Vorige sluitingsprijs	13.23

Nieuwssentiment

By Acuity

50%

141 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

16.59 / 17.17 Steun & Weerstand

Pulse Biosciences Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

2 jan 2026, 22:45 UTC

Belangrijke Marktbewegers

GH Research Shares Up, Plans to Provide Update on New Drug Application

2 jan 2026, 22:13 UTC

Marktinformatie

Winsten

Tesla Seen As Quiet on Artificial-Intelligence Efforts -- Market Talk

2 jan 2026, 21:50 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Tech, Media & Telecom Roundup: Market Talk

2 jan 2026, 21:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

2 jan 2026, 21:07 UTC

Winsten

Tesla Stock Pops and Drops After Fourth-Quarter Deliveries. -- Barrons.com

2 jan 2026, 20:09 UTC

Marktinformatie

Oil Futures Slip in First Trading Day of the Year -- Market Talk

2 jan 2026, 19:48 UTC

Marktinformatie

U.S. Natural Gas Futures Kick Off 2026 With A Loss -- Market Talk

2 jan 2026, 18:53 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

2 jan 2026, 18:53 UTC

Marktinformatie

Mexico PMIs Show Manufacturing Weakness in December -- Market Talk

2 jan 2026, 17:56 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Meta's Manus Acquisition May Help Fill AI Monetization Gap -- Market Talk

2 jan 2026, 17:50 UTC

Marktinformatie

Apparel Industry Seen With Strength Across Income Levels -- Market Talk

2 jan 2026, 17:20 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

2 jan 2026, 16:33 UTC

Marktinformatie

Remittances to Mexico Fell 5.7% in November -- Market Talk

2 jan 2026, 16:18 UTC

Marktinformatie

Tesla Dethroned as World's Largest EV Maker -- Market Talk

2 jan 2026, 15:48 UTC

Winsten

Software Has Been Battered by AI. Shopify, Veeva, and 3 More Stocks to Play a Turnaround. -- Barrons.com

2 jan 2026, 15:17 UTC

Marktinformatie

Tesla Expected to Make Its Switch to Robotics, AI in 2026 -- Market Talk

2 jan 2026, 15:01 UTC

Marktinformatie

Sable Seen Nearing Production Relaunch After Court Ruling -- Market Talk

2 jan 2026, 15:00 UTC

Winsten

The Maker of Biscoff Cookies Bets on a Global Expansion -- WSJ

2 jan 2026, 14:56 UTC

Marktinformatie

Tesla's Sales Drop Was Better Than Feared -- Market Talk

2 jan 2026, 14:20 UTC

Marktinformatie

Capstone Copper's Mantoverde Strike Could Be Costly -- Market Talk

2 jan 2026, 14:20 UTC

Marktinformatie

Global Equities Roundup: Market Talk

2 jan 2026, 14:13 UTC

Marktinformatie

Oil Futures Open Year Lower on Oversupply Concerns -- Market Talk

2 jan 2026, 13:39 UTC

Marktinformatie

U.S. Natural Gas Futures Open Year Lower -- Market Talk

2 jan 2026, 13:01 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Unicredit Could Buy Delfin's BMPS Stake, Launch Full Takeover, Equita Says -- Market Talk

2 jan 2026, 12:45 UTC

Marktinformatie

Emerging-Market Dollar Bonds Record Strong Returns in 2025 -- Market Talk

2 jan 2026, 11:48 UTC

Marktinformatie

European Gas Climbs as Cold Weather Bites -- Market Talk

2 jan 2026, 11:36 UTC

Marktinformatie

Treasury Yields, Dollar Edge Higher as Near-Term Fed Rate Cut Looks Unlikely -- Market Talk

2 jan 2026, 11:30 UTC

Marktinformatie

Copper Rally Continues, Spurred by Supply Shocks -- Market Talk

2 jan 2026, 11:29 UTC

Marktinformatie

Dollar Rises After Posting Worst Year Since 2017 -- Market Talk

2 jan 2026, 11:15 UTC

Marktinformatie

Global Energy Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Pulse Biosciences Inc Prognose

Koersdoel

By TipRanks

60.23% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 22 USD 60.23%

Hoogste 22 USD

Laagste 22 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Pulse Biosciences Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan Pulse Biosciences Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

16.59 / 17.17Steun & Weerstand

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

141 / 374 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.